Project Grant K01DA067320
Award Date 8/1/26
Completion Date 7/31/31
Dollars Obligated $200K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
- The National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health, awarded the University of California, San Diego $192,930 in project grant funding on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports mentoring in patient-oriented research on central nervous system dysfunction in individuals with HIV and substance use. The funded activities provide protected time for the principal...
- The National Institute on Drug Abuse awarded the University of California, San Diego $2.237 million on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and apply a community-informed modeling approach for HIV and hepatitis C virus prevention resource allocation among people who use drugs. The project will develop large language models trained on behavioral and biological data from multiple people-who-use-drugs cohorts to generate...
- The National Institute on Drug Abuse awarded the University of California, Los Angeles $169,776 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year research and career development project. Dr. Annette Dekker, an emergency physician and health services researcher, will lead a study evaluating how California's CA BRIDGE Initiative—a policy intervention enabling emergency departments to initiate buprenorphine treatment for opioid use...
- The National Institute on Drug Abuse awarded the University of California, San Diego $1,387,755 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate mitochondrial oxidative phosphorylation dysregulation in HIV-associated neurocognitive disorder and opioid use disorder, with NAD+ treatment as a potential therapeutic strategy. The research establishes a three-dimensional human assembloid model composed of iPSC-derived neurons, astrocytes, microglia, and...
- The National Institute on Drug Abuse awarded The Johns Hopkins University $197,320 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a K24 Midcareer Investigator Award in Patient-Oriented Research. The award provides protected time for Dr. Oluwaseun Falade-Nwulia, Associate Professor of Infectious Diseases at Johns Hopkins University, to expand a structured mentoring program for trainees and early-stage investigators focused on improving health...
- The National Institute on Drug Abuse awarded Yale University $158,545 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research and training that will adapt and pilot test integrated HIV and substance use disorder care delivery in community pharmacy settings. Dr. Tarfa, a pharmacist and PhD-trained health services researcher at Yale School of Medicine, will lead the K99 phase of this K99/R00 award through a mentorship team including specialists in HIV...
- The National Institute on Drug Abuse awarded the University of California, San Diego $138,522 under the Drug Use and Addiction Research Programs (CFDA 93.279) on January 21, 2026. The award funds research evaluating the multiscale effects of fentanyl-induced dependence and abstinence within the mouse basolateral amygdala. The research employs virally-mediated strategies, nuclear labeling, and single-nucleus RNA sequencing to assess how fentanyl dependence and abstinence differentially affect...
- The National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health, awarded The Trustees of Columbia University in the City of New York $172,160 on December 9, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a postdoctoral fellowship to examine how HIV-specific state legal policies function as barriers to perinatal care and drug use treatment engagement among pregnant women. The research employs a...
- The National Institute on Drug Abuse awarded the University of California, San Diego $4.951 million on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the Brain-Focused Research on Antiretrovirals and Methamphetamine (BRAIN-FRAME) project through March 31, 2031. The award funds research examining how long-acting injectable antiretroviral therapy (LAI-ART) and medication-assisted treatment (MAT), including LAI naltrexone, interact to improve brain...
- The National Institute on Drug Abuse awarded Hennepin Healthcare Research Institute $193,320 on July 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support development of a mentored career development award (K01) focused on improving behavioral healthcare for mothers with opioid use disorder, their children, and families. The award funds a five-year research initiative through June 30, 2031, based in Minneapolis, Minnesota. The investigator will develop a strategy...